Table of Contents
<< Previous Issue | Jan 2018 (Vol: 2018, Issue: 1) | Next Issue >> |
- Section: Mergers & Acquisitions
-
Mallinckrodt Diversifies Portfolio with US$1.2 B Acquisition of Sucampo
-
Roche Hands Over US$1.7 B for Ignyta Buyout
-
Celgene Acquires Impact Biomedicines for up to US$7 B
-
Takeda’s Strengthens Pipeline with TiGenix and Denali Deals
-
Celgene Bolsters Pipeline with US$9 B Purchase of Juno Therapeutics
-
Sanofi Acquires Haemophilia Specialist Bioverativ for US$11.6 B